These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 16701094
1. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection. Anan K, Mitsuyama S, Kuga H, Saimura M, Tanabe Y, Suehara N, Matsunaga H, Nishihara K, Abe Y, Iwashita T, Ihara T, Tamae K, Ono M, Toyoshima S. Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094 [Abstract] [Full Text] [Related]
2. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy. Noguchi M, Inokuchi M, Zen Y. J Surg Oncol; 2009 Aug 01; 100(2):100-5. PubMed ID: 19479943 [Abstract] [Full Text] [Related]
3. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. Kargozaran H, Shah M, Li Y, Beckett L, Gandour-Edwards R, Schneider PD, Khatri VP. J Surg Res; 2007 Nov 01; 143(1):126-9. PubMed ID: 17950081 [Abstract] [Full Text] [Related]
4. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer]. Ge J, Yan B, Cao XC. Zhonghua Zhong Liu Za Zhi; 2011 Mar 01; 33(3):226-8. PubMed ID: 21575525 [Abstract] [Full Text] [Related]
5. [Application of sentinel lymph node biopsy by subareolar injection of blue dye in the treatment of breast carcinoma]. Xiao H, Li ZX, Chen X, Gong JZ. Zhonghua Wai Ke Za Zhi; 2004 Jul 07; 42(13):806-7. PubMed ID: 15363301 [Abstract] [Full Text] [Related]
6. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. Lin KM, Patel TH, Ray A, Ota M, Jacobs L, Kuvshinoff B, Chung M, Watson M, Ota DM. J Am Coll Surg; 2004 Oct 07; 199(4):561-6. PubMed ID: 15454139 [Abstract] [Full Text] [Related]
7. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Murawa D, Hirche C, Dresel S, Hünerbein M. Br J Surg; 2009 Nov 07; 96(11):1289-94. PubMed ID: 19847873 [Abstract] [Full Text] [Related]
8. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Chagpar A, Martin RC, Chao C, Wong SL, Edwards MJ, Tuttle T, McMasters KM. Arch Surg; 2004 Jun 07; 139(6):614-8; discussion 618-20. PubMed ID: 15197087 [Abstract] [Full Text] [Related]
9. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors]. Huang XY, Wu J, Liu ZB, Zhang JX, Han QX, Xu WP, Ping B, Yang WT, Shen ZZ, Shao ZM. Ai Zheng; 2007 Oct 07; 26(10):1133-7. PubMed ID: 17927887 [Abstract] [Full Text] [Related]
10. [Cause of failure and false negative result in sentinel lymph node biopsy through vital blue injection in breast carcinoma]. Su F, Ba M, Zhou X, Wu X, Li Y, Chen J, Li J. Zhonghua Zhong Liu Za Zhi; 2002 May 07; 24(3):297-9. PubMed ID: 12515632 [Abstract] [Full Text] [Related]
11. [Sentinel node biopsy for breast cancer patients at the Bács-Kiskun County Teaching Hospital]. Cserni G, Rajtár M, Boross G, Sinkó M, Svébis M, Baltás B, Ambrózay E, Szúcs M. Orv Hetil; 2002 Mar 03; 143(9):437-46. PubMed ID: 12013684 [Abstract] [Full Text] [Related]
12. Blue-dye technique complements four-node sampling for early breast cancer. Ishikawa T, Momiyama N, Hamaguchi Y, Tanabe M, Tomita S, Ichikawa Y, Nakatani Y, Sasaki T, Nozawa A, Inayama Y, Inui K, Shimada H. Eur J Surg Oncol; 2005 Dec 03; 31(10):1119-24. PubMed ID: 16005597 [Abstract] [Full Text] [Related]
13. Removal of two sentinel nodes accurately stages the axilla in breast cancer. Kennedy RJ, Kollias J, Gill PG, Bochner M, Coventry BJ, Farshid G. Br J Surg; 2003 Nov 03; 90(11):1349-53. PubMed ID: 14598413 [Abstract] [Full Text] [Related]
14. Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification. Zogakis TG, Wetherille RE, Christensen RD, Ose KJ, Friedman JD, Colbert M, Svendsen CA, Sanan OK, Tuttle TM. Ann Surg Oncol; 2005 Feb 03; 12(2):167-72. PubMed ID: 15827798 [Abstract] [Full Text] [Related]
15. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients]. Kokhreidze I, Nemsadze G, Gersamia G, Dzagnidze G, Janjalia M. Georgian Med News; 2005 Apr 03; (121):7-10. PubMed ID: 15908713 [Abstract] [Full Text] [Related]
16. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. Kern KA. J Am Coll Surg; 1999 Dec 03; 189(6):539-45. PubMed ID: 10589589 [Abstract] [Full Text] [Related]
17. Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study. Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Pöstlberger S, Reitsamer R, Schrenk P. J Clin Oncol; 2006 Jul 20; 24(21):3374-80. PubMed ID: 16849751 [Abstract] [Full Text] [Related]
18. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram? Degnim AC, Oh K, Cimmino VM, Diehl KM, Chang AE, Newman LA, Sabel MS. Ann Surg Oncol; 2005 Sep 20; 12(9):712-7. PubMed ID: 16079955 [Abstract] [Full Text] [Related]
19. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer. D'Eredita' G, Giardina C, Ingravallo G, Rubini G, Lattanzio V, Berardi T. Breast; 2007 Jun 20; 16(3):316-22. PubMed ID: 17293114 [Abstract] [Full Text] [Related]
20. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer. Rzyman W, Hagen OM, Dziadziuszko R, Kobierska-Gulida G, Karmolinski A, Lothe MI, Paleczka W, Murawski M, Jastrzebski T, Kopacz A, Jassem J, Skokowski J. Eur J Surg Oncol; 2006 May 20; 32(4):462-5. PubMed ID: 16504458 [Abstract] [Full Text] [Related] Page: [Next] [New Search]